Concepedia

Lewis Mervin

LM

Statistics

Publications

25

Citations

1.3K

H-Index

19

Active since

2015

Affiliations

University of Cambridge(Current)

AstraZeneca (United Kingdom)

AstraZeneca (Sweden)

AstraZeneca (Germany)

Bayer (Germany)

Lewis Mervin is an author at University of Cambridge specializing in drug discovery, pharmacy, and medicinal chemistry.

ORCID

Publications per year

2015–2024

25

Publications

25

Reinvent 4: Modern AI–driven generative molecule design

Hannes H. Loeffler, Jiazhen He, Alessandro Tibo et al. · Journal of Cheminformatics · 2024 · 251 citations · Full text

, , +14

Target prediction utilising negative bioactivity data covering large chemical space

Lewis Mervin, Avid M. Afzal, Georgios Drakakis et al. · Journal of Cheminformatics · 2015 · 143 citations · Full text

, , +15

Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway

Chakrabhavi Dhananjaya Mohan, Venkatachalaiah Srinivasa, Shobith Rangappa et al. · PLoS ONE · 2016 · 130 citations · Full text

, , +17

MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information

Wouter Heyndrickx, Lewis Mervin, Tobias Morawietz et al. · Journal of Chemical Information and Modeling · 2023 · 115 citations · Full text

, , +17

JUMP Cell Painting dataset: morphological impact of 136,000 chemical and genetic perturbations

Srinivas Niranj Chandrasekaran, Jeanelle Ackerman, Eric Alix et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 102 citations · Full text

, , +7

1–5 of 25